Current status of artificial oxygen carriers

Advanced Drug Delivery Reviews

Volumn 40, Issue 3, 2000, Pages 143-151

  Spahn, Donat R ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Artificial oxygen carriers; Fluorocarbon emulsion; Hemoglobin solutions; Oxygen transport; Perflubron

Indexed keywords

CHEMICAL MODIFICATION; EMULSIONS; FLUOROCARBONS; HEMOGLOBIN; OXYGEN; TISSUE;

ARTIFICIAL OXYGEN CARRIERS; BLOOD TRANSFUSION; OXYGEN TRANSPORT; PERFLUBRON; TISSUE OXYGENATION;

BLOOD SUBSTITUTES;

FLUOROCARBON; HEMOGLOBIN DERIVATIVE; PERFLUOROOCTYL BROMIDE; RECOMBINANT HEMOGLOBIN;

BLOOD AUTOTRANSFUSION; BLOOD TRANSFUSION; COLLOID; DRUG DEVELOPMENT; DRUG SAFETY; EMULSION; FLU LIKE SYNDROME; HEMODILUTION; HUMAN; NONHUMAN; ORTHOPEDIC SURGERY; OXYGEN TRANSPORT; PRIORITY JOURNAL; RESUSCITATION; REVIEW; SHOCK; THROMBOCYTOPENIA; TISSUE OXYGENATION; VASOCONSTRICTION;

EID: 0343852150     PISSN: 0169409X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-409X(99)00046-0     Document Type: Article

References (51)

1. Zuck T.F., Riess J.G. Current status of injectable oxygen carriers. Crit. Rev. Clin. Lab. Sci. 31:1994;295-324.
2. Spahn D.R., Leone B.J., Reves J.G., Pasch T. Cardiovascular and coronary physiology of acute isovolemic hemodilution: a review of nonoxygen-carrying and oxygen-carrying solutions. Anesth. Analg. 78:1994;1000-1021.
3. Vlahakes G.J., Lee R., Jacobs E.E., LaRaia P.J., Austen W.G. Hemodynamic effects and oxygen transport properties of a new blood substitute in a model of massive blood replacement. J. Thorac. Cardiovasc. Surg. 100:1990;379-388.
4. Standl T., Lipfert B., Reeker W., Schulte am Esch J., Lorke D.E. Akute Auswirkungen eines kompletten Blutaustauschs mit ultragereinigter Hämoglobinlösung oder Hydroxyäthylstärke auf Leber und Niere im Tiermodell. Anasthesiol. Intensivmed. Notf. Med. Schmerzther. 31:1996;354-561.
5. Siegel J.H., Fabian M., Smith J.A., Costantino D. Use of recombinant hemoglobin solution in reversing lethal hemorrhagic hypovolemic oxygen debt shock. J. Trauma. 42:1997;199-212.
6. Xu L., Sun L., Rollwagen F.M., Li Y., Pacheco N.D., Pikoulis E., Leppaniemi A., Soltero R., Burris D., Malcolm D., Nielsen T.B. Cellular responses to surgical trauma, hemorrhage, and resuscitation with diaspirin cross-linked hemoglobin in rats. J. Trauma. 42:1997;32-41.
7. Hebert P.C., Hu L.Q., Biro G.P. Review of physiologic mechanisms in response to anemia. Can. Med. Assoc. J. 156:1997;S27-S40.
8. Fitzgerald R.D., Martin C.M., Dietz G.E., Doig G.S., Potter R.F., Sibbald W.J. Transfusing red blood cells stored in citrate phosphate dextrose adenine-1 for 28 days fails to improve tissue oxygenation in rats. Crit. Care Med. 25:1997;726-732.
9. Standl T., Horn P., Wilhelm S., Greim C., Freitag M., Freitag U., Sputtek A., Jacobs E., Schulte am Esch J. Bovine haemoglobin is more potent than autologous red blood cells in restoring muscular tissue oxygenation after profound isovolaemic haemodilution in dogs. Can. J. Anaesth. 43:1996;714-723.
10. Horn E.P., Standl T., Wilhelm S., Jacobs E.E., Freitag U., Freitag M., Esch J.S.A. Bovine hemoglobin increases skeletal muscle oxygenation during 95 percent artificial arterial stenosis. Surgery. 121:1997;411-418.
11. DeAngeles D.A., Scott A.M., McGrath A.M., Korent V.A., Rodenkirch L.A., Conhaim R.L., Harms B.A. Resuscitation from hemorrhagic shock with diaspirin cross-linked hemoglobin, blood, or hetastarch. J. Trauma. 42:1997;406-412.
12. Viele M.K., Weiskopf R.B., Fisher D. Recombinant human hemoglobin does not affect renal function in humans: analysis of safety and pharmacokinetics. Anesthesiology. 86:1997;848-858.
13. Przybelski R.J., Daily E.K., Kisicki J.C., Mattia Goldberg C., Bounds M.J., Colburn W.A. Phase I study of the safety and pharmacologic effects of diaspirin cross-linked hemoglobin solution. Crit. Care Med. 24:1996;1993-2000.
14. Jia L., Bonaventura J., Stamler J.S. S-Nitrosohaemoglobin: a dynamic activity of blood involved in vascular control. Nature. 380:1996;221-226.
15. Kasper S.M., Walter M., Grüne F., Bischoff A., Erasmi H., Buzello W. Effects of a hemoglobin-based oxygen carrier (HBOC-201) on hemodynamics and oxygen transport in patients undergoing preoperative hemodilution for elective abdominal aortic surgery. Anesth. Analg. 83:1996;921-970.
16. Dietz N.M., Martin C.M., Beltrandelrio A.G., Joyner M.J. The effects of cross linked hemoglobin on regional vascular conductance in dogs. Anesth. Analg. 85:1997;265-273.
17. Gulati A., Sharma A.C., Singh G. Role of endothelin in the cardiovascular effects of diaspirin crosslinked and stroma reduced hemoglobin. Crit. Care Med. 24:1996;137-147.
18. Gulati A., Rebello S. Role of adrenergic mechanisms in the pressor effect of diaspirin cross-linked hemoglobin. J. Lab. Clin. Med. 124:1994;125-133.
19. Gould S.A., Moss G.S. Clinical development of human polymerized hemoglobin as a blood substitute. World J. Surg. 20:1996;1200-1700.
20. Keipert P.E., Gomez C.L., Gonzales A., MacDonald V.W., Hess J.R., Winslow R.M. Diaspirin cross-linked hemoglobin: tissue distribution and long-term excretion after exchange transfusion. J. Lab. Clin. Med. 123:1994;701-711.
21. Bleeker W.K., van der Plas J., Feitsma R.I., Agterberg J., Rigter G., de Vries van Rossen A., Pauwels E.K., Bakker J.C. In vivo distribution and elimination of hemoglobin modified by intramolecular cross-linking with 2-nor-2-formylpyridoxal 5′-phosphate. J. Lab. Clin. Med. 113:1989;151-161.
22. Schultz S.C., Grady B., Cole F., Hamilton I., Burhop K., Malcolm D.S. A role for endothelin and nitric oxide in the pressor response to diaspirin cross-linked hemoglobin. J. Lab. Clin. Med. 122:1993;301-308.
23. Bickell W.H., Wall M.J., Pepe P.E., Martin R.R., Ginger V.F., Allen M.K., Mattox K.L. Immediate versus delayed fluid resuscitation for hypotensive patients with penetrating torso injuries. New Engl. J. Med. 331:1994;1105-1190.
24. Gulati A., Sen A.P. Dose-dependent effect of diaspirin cross-linked hemoglobin on regional blood circulation of severely hemorrhaged rats. Shock. 9:1998;65-73.
25. Reah G., Bodenham A.R., Mallick A., Daily E.K., Przybelski R.J. Initial evaluation of diaspirin cross-linked hemoglobin (DCLHb) as a vasopressor in critically ill patients. Crit. Care Med. 25:1997;1480-1488.
26. Baron J.F., Berridge J., Brichant J.F., Demeyere R., Lamy M., Larbuisson R., Lehot J.J., Parsloe M., Sinclair C.J., Vandermeersch E. Group THCSTC. The use of Diaspirin crosslinked hemoglobin (DCLHb) as an alternative to blood transfusion in cardiac surgery patients following cardiopulmonary bypass: a pivotal efficacy trial. Anesthesiology. 87:1997;A217.
27. Standl T., Wilhelm S., Horn E.P., Burmeister M., Gundlach M., Schulte am Esch J. Präoperative Hämodilution mit bovinem Hämoglobin: Akute hämodynamische Auswirkungen bei Patienten in der Leberchirurgie. Anaesthesist. 46:1997;763-770.
28. Gould S.A., Moore E.E., Moore F.A., Haenel J.B., Burch J.M., Sehgal H., Sehgal L., DeWoskin R., Moss G.S. Clinical utility of human polymerized hemoglobin as a blood substitute after acute trauma and urgent surgery. J. Trauma. 43:1997;325-331.
29. Standl T., Burmeister M.A., Horn E.P., Wilhelm S., Knoefel W.T., Esch J.S.A. Bovine haemoglobin-based oxygen carrier for patients undergoing haemodilution before liver resection. Br. J. Anaesth. 80:1998;189-194.
30. Ma Z., Monk T.G., Goodnough L.T., McClellan A., Gawryl M., Clark T., Moreira P., Keipert P.E., Scott M.G. Effect of hemoglobin- and Perflubron-based oxygen carriers on common clinical laboratory tests. Clin. Chem. 43:1997;1732-1770.
31. Reppucci A.J., Mattia Goldberg C., Przybelski R.J., Kuczerepa P.R., Balma D.L. The effects of diaspirin crosslinked hemoglobin on the assessment of immunohematology profiles. Transfusion. 37:1997;1143-1180.
32. Patel M.J., Webb E.J., Shelbourn T.E., Mattia Goldberg C., George A.J., Zhang F., Moore E.G., Nelson D.J. Absence of immunogenicity of diaspirin cross-linked hemoglobin in humans. Blood. 91:1998;710-760.
33. Riess J.G. Overview of progress in the fluorocarbon approach to in vivo oxygen delivery. Biomater. Artif. Cells Immobilization Biotechnol. 20:1992;183-202.
34. Wahr J.A., Trouwborst A., Spence R.K., Henny C.P., Cernaianu A.C., Graziano G.P., Tremper K.K., Flaim K.E., Keipert P.E., Faithfull N.S., Clymer J.J. A pilot study of the effects of a perflubron emulsion, A.F. 0104, on mixed venous oxygen tension in anesthetized surgical patients. Anesth. Analg. 82:1996;103-170.
35. Keipert P.E. Perfluorochemical emulsions: future alternatives to transfusion. Blood Subst. Princ. Meth. Prod. Clin. Trials. 2:1998;127-156.
36. Young L.H., Jaffe C.C., Revkin J.H., McNulty P.H., Cleman M. Metabolic and functional effects of perfluorocarbon distal perfusion during coronary angioplasty. Am. J. Cardiol. 65:1990;986-990.
37. Kent K.M., Cleman M.W., Cowley M.J., Forman M.B., Jaffe C.C., Kaplan M., King S.D., Krucoff M.W., Lassar T., McAuley B., Smith R., Wisdom C., Wohlgelernter D. Reduction of myocardial ischemia during percutaneous transluminal coronary angioplasty with oxygenated Fluosol. Am. J. Cardiol. 66:1990;279-284.
38. Keipert P.E., Faithfull N.S., Bradley J.D., Hazard D.Y., Hogan J., Levisetti M.S., Peters R.M. Oxygen delivery augmentation by low-dose perfluorochemical emulsion during profound normovolemic hemodilution. Adv. Exp. Med. Biol. 345:1994;197-204.
39. Holman W.L., Spruell R.D., Ferguson E.R., Clymer J.J., Vicente W.V., Murrah C.P., Pacifico A.D. Tissue oxygenation with graded dissolved oxygen delivery during cardiopulmonary bypass. J. Thorac. Cardiovasc. Surg. 110:1995;774-785.
40. O2 in brain cortex of unanaesthetized rabbits. Adv. Exp. Med. Biol. 411:1997;403-900.
41. Stern S.A., Dronen S.C., McGoron A.J., Wang X., Chaffins K., Millard R., Keipert P.E., Faithfull N.S. Effect of supplemental perfluorocarbon administration on hypotensive resuscitation of severe uncontrolled hemorrhage. Am. J. Emerg. Med. 13:1995;269-275.
42. Manning J.E., Batson D.N., Payne F.B., Adam N., Murphy C.A., Perretta S.G., Norfleet E.A. Selective aortic arch perfusion during cardiac arrest: enhanced resuscitation using oxygenated perflubron emulsion, with and without aortic arch epinephrine. Ann. Emerg. Med. 29:1997;580-587.
43. Habler O.P., Kleen M.S., Hutter J.W., Podtschaske A.H., Tiede M., Kemming G.I., Welte M.V., Corso C.O., Batra S., Keipert P.E., Faithfull N.S., Messmer K.F. Effects of hyperoxic ventilation on hemodilution-induced changes in anesthetized dogs. Transfusion. 38:1998;135-144.
44. Habler O.P., Kleen M.S., Hutter J.W., Podtschaske A.H., Tiede M., Kemming G.I., Welte M.V., Corso C.O., Batra S., Keipert P.E., Faithfull N.S., Messmer K.F. Hemodilution and intravenous perflubron emulsion as an alternative to blood transfusion: effects on tissue oxygenation during profound hemodilution in anesthetized dogs. Transfusion. 38:1998;145-155.
45. O.P. Habler, M.S. Kleen, J.W. Hutter, A.H. Podtschaske, M. Tiede, G.I. Kemming, M.V. Welte, C.O. Corso, S. Batra, P.E. Keipert, N.S. Faithful, K.F. Messmer, Iv perflubron emulsion versus autologous transfusion in severe normovolemic anemia: effects on left ventricular perfusion and function, Res. Exp. Med. (in press).
46. Spahn D.R., van Brempt R., Theilmeier G., Reibold J.-P., Welte M., Heinzerling H., Birck K.M., Keipert P.E., Messmer K. Perflubron emulsion delays blood transfusions in orthopedic surgery. Anesthiology. 91:1991;1195-1208.
47. Keipert P.E., Faithfull N.S., Roth D.J., Bradley J.D., Batra S., Jochelson P., Flaim K.E. Supporting tissue oxygenation during acute surgical bleeding using a perfluorochemical-based oxygen carrier. Adv. Exp. Med. Biol. 388:1996;603-690.
48. Egli G.A., Zollinger A., Seifert B., Popovic D., Pasch T., Spahn D.R. Effect of progressive haemodilution with hydroxyethyl starch, gelatin and albumin on blood coagulation. Br. J. Anaesth. 78:1997;684-689.
49. Practice guidelines for blood component therapy. Anesthesiology. 84:1996;732-747.
50. Looker D., Abbott-Brown D., Cozart P., Durfee S., Hoffman S., Mathews A.J., Miller-Roerich J., Shoemaker S., Trimble S., Fermi G., Komiyama N.H., Nagai K., Stetler G.L. A human recombinant haemoglobin designed for use as a blood substitute. Nature. 356:1992;258-260.
51. Dieryck W., Pagnier J., Poyart C., Marden M.C., Gruber V., Bournat P., Baudino S., Merot B. Human haemoglobin from transgenic tobacco. Nature. 386:1997;29-30.